依帕司他联合抗氧化剂治疗糖尿病周围神经病变患者震动感觉阈值的对比分析

胡雪剑, 任建功, 罗晖, 杨燕

中国医院药学杂志 ›› 2016, Vol. 36 ›› Issue (12) : 1022-1024.

PDF(444 KB)
PDF(444 KB)
中国医院药学杂志 ›› 2016, Vol. 36 ›› Issue (12) : 1022-1024. DOI: 10.13286/j.cnki.chinhosppharmacyj.2016.12.16
药物与临床

依帕司他联合抗氧化剂治疗糖尿病周围神经病变患者震动感觉阈值的对比分析

  • 胡雪剑, 任建功, 罗晖, 杨燕
作者信息 +

Comparative analysis of vibration perception thresholds in patients with diabetic peripheral neuropathy treated by epalrestat combined with antioxidants

  • HU Xue-jian, REN Jian-gong, LUO Hui, YANG Yan
Author information +
文章历史 +

摘要

目的:观察依帕司他联合抗氧化剂治疗糖尿病周围神经病变患者对震动感觉阈值的影响,评价依帕司他联合抗氧化剂治疗糖尿病周围神经病变的疗效。方法:84例糖尿病周围神经病变患者随机分为2组,治疗组给予依帕司他联合抗氧化剂治疗,对照组单用抗氧化剂治疗,疗程3周,治疗前后进行震动感觉阈值检测。结果:对照组有效率为78.6%,治疗组为92.9%,2组比较有统计学意义(P<0.05);与观察组相比,治疗组的震动感觉阈值数值下降,有较好改善,2组比较有统计学意义(P<0.05)。结论:依帕司他联合抗氧化剂治疗优于单用抗氧化剂治疗,可明显改善震动感觉阈值数值,减轻临床症状,有较好的疗效。

Abstract

OBJECTIVE To observe vibration perception threshold in patients with diabetic peripheral neuropathy treated by epalrestat combined with anti-oxidants,and evaluate efficacy of combined therapy.METHODS A total of 84 cases of diabetic peripheral neuropathy were randomly divided into two groups.Patients received epalrestat combined with anti-oxidants in treatment group,antioxidants in control group.Drugs were administered daily,for 3 weeks continuously.Vibration perception threshold was determined in two groups before and after treatment.RESULTS Effective rate was 92.9% in treatment group and 78.6% in control group (P<0.05).Compared to control group,vibration perception threshold declined significantly in treatment group (P<0.05).CONCLUSION Epalrestat combined with antioxidants has superior efficacy to antioxidants alone to treat diabetic peripheral neuropathy.Combined therapy can decline values of vibration perception threshold and reduce symptoms for diabetic peripheral neuropathy.

关键词

糖尿病周围神经病变 / 依帕司他 / 震动感觉阈值

Key words

diabetic peripheral neuropathy / epalrestat / vibration perception threshold

引用本文

导出引用
胡雪剑, 任建功, 罗晖, 杨燕. 依帕司他联合抗氧化剂治疗糖尿病周围神经病变患者震动感觉阈值的对比分析[J]. 中国医院药学杂志, 2016, 36(12): 1022-1024 https://doi.org/10.13286/j.cnki.chinhosppharmacyj.2016.12.16
HU Xue-jian, REN Jian-gong, LUO Hui, YANG Yan. Comparative analysis of vibration perception thresholds in patients with diabetic peripheral neuropathy treated by epalrestat combined with antioxidants[J]. Chinese Journal of Hospital Pharmacy, 2016, 36(12): 1022-1024 https://doi.org/10.13286/j.cnki.chinhosppharmacyj.2016.12.16
中图分类号: R969   

参考文献

[1] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中国医学前沿杂志:电子版,2015,22(3):26-89.
[2] Harati Y.Diabetic neuropathies:Unanswered questions[J].Neurologic Clinics,2007,25(1):303.
[3] 沈娟,曾辉,李连喜,等.振动感觉阈值(VPT)在糖尿病周围神经病变(DPN)中的诊断价值[J].复旦学报:医学版,2013,40(1):31-37.
[4] 魏桂蓉.前列地尔联合依帕司他对糖尿病周围神经病变的疗效[J].中国老年学杂志,2012,32(9):1804-1805.
[5] Ohmura C,Watada H,Azuma K,et al.Aldose reducetase inhibitor,epalrestat,reduces lipid hydroperoxides in type 2 diabetes[J].Endocr J,2009,56(1):149-156.
[6] 刘江华,邓国宝,刘志文,等.氯沙坦联合弥可保治疗糖尿病周围神经病变的临床研究[J].中国实用内科杂志,2003,23(6):357-358.
[7] Boulton AJ,Vinik AI,Arezzo JC,et al.Diabetic neuropathies:a statement by the American Diabetes Association[J].Diabetes Care,2005,28(4):956-962.
[8] Mantin CL,Waberski BH,Pop-Busui R,et al.Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes:results from the DCCT/EDIC study[J].Diabetes Care,2010,33(12):2635-2641.

PDF(444 KB)

80

Accesses

0

Citation

Detail

段落导航
相关文章

/